BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28612242)

  • 21. Histopathological classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a nationwide Japanese prospective 2-year follow-up cohort study.
    Yamagata K; Usui J; Nagata M; Sugiyama H; Sada KE; Muso E; Harigai M; Amano K; Atsumi T; Fujimoto S; Yuzawa Y; Kobayashi M; Saito T; Ito T; Hirawa N; Homma S; Dobashi H; Tsuboi N; Ishizu A; Arimura Y; Makino H; Matsuo S;
    Clin Exp Nephrol; 2019 Mar; 23(3):387-394. PubMed ID: 30306344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.
    Khalighi MA; Wang S; Henriksen KJ; Bock M; Keswani M; Chang A; Meehan SM
    Pediatr Nephrol; 2015 Jun; 30(6):953-9. PubMed ID: 25669759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors.
    Tanna A; Guarino L; Tam FW; Rodriquez-Cubillo B; Levy JB; Cairns TD; Griffith M; Tarzi RM; Caplin B; Salama AD; Cook T; Pusey CD
    Nephrol Dial Transplant; 2015 Jul; 30(7):1185-92. PubMed ID: 25016608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Geetha D; Sethi S; De Vriese AS; Specks U; Kallenberg CGM; Lim N; Spiera R; St Clair EW; Merkel PA; Seo P; Monach PA; Lepori N; Fessler BJ; Langford CA; Hoffman GS; Sharma R; Stone JH; Fervenza FC;
    Am J Nephrol; 2017; 46(3):231-238. PubMed ID: 28881339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
    Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
    Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopatological classification schema and review of the literature.
    Moroni G; Binda V; Leoni A; Raffiotta F; Quaglini S; Banfi G; Messa P
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-56-63. PubMed ID: 26016751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center.
    Chang DY; Wu LH; Liu G; Chen M; Kallenberg CG; Zhao MH
    Nephrol Dial Transplant; 2012 Jun; 27(6):2343-9. PubMed ID: 22121235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement in ANCA-associated glomerulonephritis.
    Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
    Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manifest interstitial and vascular pathology in anti-neutrophil cytoplasmic antibody-associated renal disease.
    Haridasan S; Ganesh RN; Parameswaran S; Priyamvada PS
    Saudi J Kidney Dis Transpl; 2019; 30(3):726-734. PubMed ID: 31249242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
    Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
    Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study.
    Bjørneklett R; Bostad L; Fismen AS
    Biomed Res Int; 2018; 2018():7581567. PubMed ID: 29955611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relation between histopathological classification and renal outcome, ANCA subtype and treatment regimens in ANCA-associated vasculitis.
    Kristensen T; Gregersen JW; Krag SR; Ivarsen P
    Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S105-10. PubMed ID: 27241586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis.
    Wacrenier S; Riou J; Jourdain P; Guibert F; Henry N; Djema A; Coindre JP; Crochette R; Cousin M; Croue A; Subra JF; Piccoli G; Augusto JF; Brilland B
    Nephrol Dial Transplant; 2022 May; 37(6):1078-1087. PubMed ID: 33856482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts.
    Muso E; Endo T; Itabashi M; Kakita H; Iwasaki Y; Tateishi Y; Komiya T; Ihara T; Yumura W; Sugiyama T; Joh K; Suzuki K
    Clin Exp Nephrol; 2013 Oct; 17(5):659-662. PubMed ID: 23263238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ANCA-associated vasculitis with renal involvement.
    Binda V; Moroni G; Messa P
    J Nephrol; 2018 Apr; 31(2):197-208. PubMed ID: 28560688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a renal risk score in a cohort of ANCA-associated vasculitis patients with severe kidney damage.
    Mejía-Vilet JM; Martín-Nares E; Cano-Verduzco ML; Pérez-Arias AA; Sedano-Montoya MA; Hinojosa-Azaola A
    Clin Rheumatol; 2020 Jun; 39(6):1935-1943. PubMed ID: 31970548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological classification of antineutrophil cytoplasmic antibody-associated glomerulonephritis: an update.
    Rahmattulla C; Bruijn JA; Bajema IM
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):224-31. PubMed ID: 24675139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating renal survival using the ANCA-associated GN classification.
    Hilhorst M; Wilde B; van Breda Vriesman P; van Paassen P; Cohen Tervaert JW;
    J Am Soc Nephrol; 2013 Sep; 24(9):1371-5. PubMed ID: 23766532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
    Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological Classification-A Prognostic Tool for Rapidly Progressive Glomerulonephritis.
    Kantauskaitė M; Laučytė-Cibulskienė A; Miglinas M
    Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.